Chronic Eosinophilic Leukemia: Clinical Trials

21 trials for Chronic Eosinophilic Leukemia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

18 completed, 1 active not recruiting, 1 terminated, 1 withdrawn. 6 Not applicable, 6 Phase 1, 6 Phase 2, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable6Completed 5, Withdrawn 1
Phase 16Completed 6
Phase 26Completed 5, Terminated 1
Phase 32Completed 2

Follow Chronic Eosinophilic Leukemia: new trials by email Literature Review of Chronic Eosinophilic Leukemia trials Research Report on Chronic Eosinophilic Leukemia

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Vaccine Therapy in Preventing Cytomegalovirus Infection in Patients With Hematological Malignancies Undergoing Donor Stem Cell Transplant
tetanus-CMV fusion peptide vaccine, laboratory biomarker analysis - Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission
Phase 1CompletedCity of Hope Medical Center362012-10-292024-04-02
Mechanical Stimulation in Preventing Bone Density Loss in Patients Undergoing Donor Stem Cell Transplant
management of therapy complications, musculoskeletal complications management/prevention - Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission
Not applicableWithdrawnRoswell Park Cancer Institute2012-05-012012-07-09
A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies
Fludarabine, Busulfan, Total Body Irradiation (TBI) - Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission
Phase 2CompletedSidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University402011-08-042026-04-15
Supersaturated Calcium Phosphate Rinse in Preventing Oral Mucositis in Young Patients Undergoing Autologous or Donor Stem Cell Transplant
supersaturated calcium phosphate rinse, placebo, questionnaire administration - Childhood Acute Lymphoblastic Leukemia in Remission, Childhood Acute Myeloid Leukemia in Remission
Phase 3CompletedChildren's Oncology Group2262011-03-012019-09-17
Prolonged or Standard Infusion of Cefepime Hydrochloride in Treating Patients With Febrile Neutropenia
cefepime hydrochloride - Adult Acute Lymphoblastic Leukemia, Adult Acute Myeloid Leukemia
Phase 1CompletedWake Forest University Health Sciences702011-02-012018-07-18
Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant
infection prophylaxis and management, laboratory biomarker analysis, flow cytometry - Hematopoietic/Lymphoid Cancer, Accelerated Phase Chronic Myelogenous Leukemia
Active not recruitingCity of Hope Medical Center1532011-01-112026-10-22
MK2206 in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Leukemia
Akt inhibitor MK2206, diagnostic laboratory biomarker analysis, pharmacological study - Accelerated Phase Chronic Myelogenous Leukemia, Acute Leukemias of Ambiguous Lineage
Phase 1CompletedNational Cancer Institute (NCI)452011-01-012014-04-29
Palifermin in Preventing Chronic Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer
palifermin, flow cytometry, laboratory biomarker analysis - Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission
Not applicableCompletedMartin, Paul62010-09-012014-04-02
Deferasirox for Treating Patients Who Have Undergone Allogeneic Stem Cell Transplant and Have Iron Overload
deferasirox - Iron Overload, Accelerated Phase Chronic Myelogenous Leukemia
Phase 2TerminatedCity of Hope Medical Center12010-07-012019-06-18
Massage Therapy Given by Caregiver in Treating Quality of Life of Young Patients Undergoing Treatment for Cancer
massage therapy, questionnaire administration, quality-of-life assessment - Accelerated Phase Chronic Myelogenous Leukemia, Acute Undifferentiated Leukemia
Not applicableCompletedWake Forest University Health Sciences802010-04-012018-07-02
Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy
sunitinib malate, pharmacological study, laboratory biomarker analysis - Accelerated Phase Chronic Myelogenous Leukemia, Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome
Phase 1CompletedNational Cancer Institute (NCI)422009-08-012014-03-17
Fludarabine Phosphate, Melphalan, Total-Body Irradiation, Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Bone Marrow Failure Disorders
fludarabine phosphate, melphalan, total-body irradiation - Accelerated Phase Chronic Myelogenous Leukemia, Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome
Not applicableCompletedRoswell Park Cancer Institute622009-01-142019-11-13
Ondansetron in Preventing Nausea and Vomiting in Patients Undergoing Stem Cell Transplant
ondansetron, survey administration, management of therapy complications - Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission
Phase 2CompletedFred Hutchinson Cancer Center492008-08-082017-05-23
Internet-Based Program With or Without Telephone-Based Problem-Solving Training in Helping Long-Term Survivors of Hematopoietic Stem Cell Transplant Cope With Late Complications
internet-based intervention, questionnaire administration, psychosocial assessment and care - Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission
Phase 3CompletedFred Hutchinson Cancer Research Center/University of Washington Cancer Consortium13372008-08-012012-03-07
Beclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer
beclomethasone dipropionate, placebo, tacrolimus - Hematopoietic/Lymphoid Cancer, Accelerated Phase Chronic Myelogenous Leukemia
Phase 2CompletedFred Hutchinson Cancer Center1402007-04-012021-02-03
3-AP and Fludarabine in Treating Patients With Myeloproliferative Disorders, Chronic Myelomonocytic Leukemia, or Accelerated Phase or Blastic Phase Chronic Myelogenous Leukemia
fludarabine phosphate, triapine, laboratory biomarker analysis - Accelerated Phase Chronic Myelogenous Leukemia, Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative
Phase 2CompletedNational Cancer Institute (NCI)352006-08-012015-01-06
Lithium Carbonate in Treating Patients With Acute Intestinal Graft-Versus-Host-Disease (GVHD) After Donor Stem Cell Transplant
lithium carbonate, laboratory biomarker analysis - Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission
Not applicableCompletedFred Hutchinson Cancer Center202006-06-012017-03-07
Vorinostat, Cytarabine, and Etoposide in Treating Patients With Relapsed and/or Refractory Acute Leukemia or Myelodysplastic Syndromes or Myeloproliferative Disorders
vorinostat, cytarabine, etoposide - Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Basophilic Leukemia
Phase 1CompletedNational Cancer Institute (NCI)252006-05-012013-05-03
Efficacy of Imatinib Mesylate in Hypereosinophilic Syndromes
Imatinib - Hypereosinophilic Syndrome, Chronic Eosinophilic Leukemia
Phase 2CompletedNorthern Italy Leukemia Group252004-10-012010-12-29
Imatinib Mesylate in Treating Patients With Advanced Cancer and Liver Dysfunction
imatinib mesylate, pharmacological study - Accelerated Phase Chronic Myelogenous Leukemia, Acute Undifferentiated Leukemia
Phase 1CompletedNational Cancer Institute (NCI)602001-08-012013-02-07

Showing 20 of 21. Sign in to see all of them.

Narrower conditions

Pdgfra-Associated Chronic Eosinophilic Leukemia (21)  ·  Leukemia, Myelomonocytic, Chronic (20)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (19)  ·  Leukemia, Neutrophilic, Chronic (18)  ·  Primary Myelofibrosis (18)  ·  Burkitt Lymphoma (17)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (17)  ·  Leukemia, Myeloid, Accelerated Phase (17)  ·  Leukemia, Myeloid, Acute (16)  ·  Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative (16)  ·  Lymphoma, B-Cell, Marginal Zone (16)  ·  Lymphoma, Follicular (16)  ·  Lymphoma, Large B-Cell, Diffuse (16)  ·  Lymphoma, T-Cell, Cutaneous (16)  ·  Mycosis Fungoides (16)

Broader conditions

Hematologic Diseases (21)  ·  Hemic and Lymphatic Diseases (21)  ·  Bone Marrow Diseases (20)  ·  Chronic Disease (20)  ·  Disease Attributes (20)  ·  Leukemia, Myeloid (20)  ·  Neoplasms (20)  ·  Neoplasms by Histologic Type (20)  ·  Pathologic Processes (20)  ·  Pathological Conditions, Signs and Symptoms (20)  ·  Immune System Diseases (19)  ·  Immunoproliferative Disorders (19)  ·  Leukemia (19)  ·  Leukemia, Lymphoid (19)  ·  Lymphatic Diseases (19)

Interventions

fludarabine phosphate (4)  ·  Therapeutics (3)  ·  Whole-Body Irradiation (3)  ·  Flow Cytometry (2)  ·  Imatinib Mesylate (2)  ·  Mycophenolic Acid (2)  ·  Peripheral Blood Stem Cell Transplantation (2)  ·  Tacrolimus (2)  ·  3-aminopyridine-2-carboxaldehyde thiosemicarbazone (1)  ·  Antilymphocyte Serum (1)  ·  Antiviral Agents (1)  ·  Beclomethasone (1)  ·  Busulfan (1)  ·  Cefepime (1)  ·  Counseling (1)

Sponsors

National Cancer Institute (NCI) (5)  ·  Fred Hutchinson Cancer Center (4)  ·  City of Hope Medical Center (3)  ·  Roswell Park Cancer Institute (2)  ·  Wake Forest University Health Sciences (2)  ·  Children's Oncology Group (1)  ·  Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium (1)  ·  Martin, Paul (1)  ·  Northern Italy Leukemia Group (1)  ·  Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University (1)

Countries

United States (19)  ·  Canada (2)  ·  Australia (1)  ·  Italy (1)

Top investigators

Paul Martin (3)  ·  Ryotaro Nakamura (2)  ·  Ann Woolfrey (1)  ·  Douglas Ross (1)  ·  George Chen (1)  ·  Janet Tooze, PhD (1)  ·  John Deeken (1)  ·  John Williamson (1)  ·  Judith Karp (1)  ·  Karen Syrjala (1)  ·  Leona Holmberg (1)  ·  Maryam Fouladi (1)  ·  Nathaniel Treister, MD (1)  ·  Philip McCarthy (1)  ·  Ramesh Ramanathan (1)

Results publications

PMID 18698002, PMID 19735261, PMID 22259028, PMID 24362550, PMID 24474568, PMID 26853648, PMID 28817727, PMID 30562587, PMID 32628342, PMID 33420905, PMID 36282798

NIH funding

P01CA018029 (1), P30CA006973 (1), P30CA015704 (1), R01CA112631 (1), U01CA062487 (1), U01CA062491 (1), U01CA062502 (1), U01CA062505 (1), U01CA070095 (1), U01CA097452 (1), U01CA099168 (1), U01CA121947 (1), U10CA095861 (1)